We are thrilled to announce our participation in Advanced Therapies USA 2024, happening in Philadelphia from November 12th to 13th. This premier event focuses on advancing cell and gene therapies and offers unique opportunities for collaboration, networking, and learning. Featuring 200 expert speakers and over 1,000 attendees, the conference presents 8 specialized content tracks, innovation showcases, and a start-up village for emerging companies. Attendees can explore cutting-edge advancements and engage in one-on-one meetings to accelerate the development of next-generation therapies.
What is Advanced Therapies USA?
Advanced Therapies USA 2024 brings together global leaders in cell and gene therapy to share insights, drive collaboration, and accelerate the development of next-generation medicines. The conference focuses on advancing research, improving commercialization, and ultimately enhancing patient lives. Through diverse sessions, networking opportunities, and innovative showcases, the event aims to shape the future of advanced therapies and promote breakthroughs in healthcare.
Event Overview
Venue: Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107
Dates: November 21st to 22nd, 2024
- Conference Day 1: Tuesday, 12 November,, 2024, 8:30 AM - 5:00 PM
- Conference Day 2: Wednesday, 13 November, 2024, 8:30 AM - 5:00 PM
Booth #211
Event Schedule
The Advanced Therapies USA 2024 agenda features two days packed with insightful keynotes, expert-led track sessions, and panel discussions on topics like cell therapy, gene therapy, manufacturing, and supply chain. For full details, refer to the Advanced Therapies USA agenda.
Day 1: November 12, 2024
- Keynote 1 – State of the Industry from 8:30 AM to 9:00 AM
- Track Sessions from 9:00 AM to 10:00 AM
- Track 1: Evidence, Pricing & Access
- Track 2: Gene Modified Cell Therapy
- Track 3: Cell Therapy
- Track 4: Gene Therapy
- Track 5: Cell Therapy Manufacture
- Track 6: Viral Vector Manufacture
- Track 7: Supply Chain & Logistics
- Track 8: Innovation Showcase
- Morning Tea Break from 10:00 AM to 10:20 AM
- Panel Discussions and Sponsored Presentations across all tracks from 10:20 AM to 12:10 PM
- Lunch Break from 12:10 PM to 12:50 PM
- Continued Track Sessions and Panels from 12:50 PM to 2:10 PM
- Roundtables, Networking, and Panel Sessions from 2:10 PM to 3:30 PM
- Afternoon Tea and Networking from 3:30 PM to 4:30 PM
- Keynote 2 and Closing Panels from 4:30 PM to 5:50 PM
- Networking Drinks Reception from 5:50 PM
Day 2: November 13, 2024
- Keynote 3 – The Next Generation of ATMPs from 8:30 AM to 9:00 AM
- Track Sessions from 9:00 AM to 10:00 AM
- Track 1: Commercialisation
- Track 2: Immunotherapy
- Track 3: Cell Therapy
- Track 4: Gene Editing
- Track 5: Cell Therapy Manufacture
- Track 6: Viral Vector Manufacture
- Track 7: Supply Chain & Logistics
- Track 8: Innovation Showcase
- Morning Tea Break from 10:00 AM to 10:20 AM
- Panel Discussions and Sponsored Presentations across all tracks from 10:20 AM to 12:10 PM
- Lunch Break from 12:10 PM to 12:50 PM
- Continued Track Sessions and Panels from 12:50 PM to 2:10 PM
- Roundtables, Networking, and Panel Sessions from 2:10 PM to 3:30 PM
- Afternoon Tea and Networking from 3:30 PM to 4:30 PM
- Closing Remarks and Networking from 4:30 PM to 5:00 PM
About KACTUS
KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.
